BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 12642696)

  • 1. Single-nucleotide polymorphism (SNP) analysis in the ABC half-transporter ABCG2 (MXR/BCRP/ABCP1).
    Honjo Y; Morisaki K; Huff LM; Robey RW; Hung J; Dean M; Bates SE
    Cancer Biol Ther; 2002; 1(6):696-702. PubMed ID: 12642696
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Single nucleotide polymorphisms result in impaired membrane localization and reduced atpase activity in multidrug transporter ABCG2.
    Mizuarai S; Aozasa N; Kotani H
    Int J Cancer; 2004 Mar; 109(2):238-46. PubMed ID: 14750175
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Natural allelic variants of breast cancer resistance protein (BCRP) and their relationship to BCRP expression in human intestine.
    Zamber CP; Lamba JK; Yasuda K; Farnum J; Thummel K; Schuetz JD; Schuetz EG
    Pharmacogenetics; 2003 Jan; 13(1):19-28. PubMed ID: 12544509
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Re-evaluation and functional classification of non-synonymous single nucleotide polymorphisms of the human ATP-binding cassette transporter ABCG2.
    Tamura A; Wakabayashi K; Onishi Y; Takeda M; Ikegami Y; Sawada S; Tsuji M; Matsuda Y; Ishikawa T
    Cancer Sci; 2007 Feb; 98(2):231-9. PubMed ID: 17297656
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The multidrug-resistant phenotype associated with overexpression of the new ABC half-transporter, MXR (ABCG2).
    Litman T; Brangi M; Hudson E; Fetsch P; Abati A; Ross DD; Miyake K; Resau JH; Bates SE
    J Cell Sci; 2000 Jun; 113 ( Pt 11)():2011-21. PubMed ID: 10806112
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Single nucleotide polymorphisms modify the transporter activity of ABCG2.
    Morisaki K; Robey RW; Ozvegy-Laczka C; Honjo Y; Polgar O; Steadman K; Sarkadi B; Bates SE
    Cancer Chemother Pharmacol; 2005 Aug; 56(2):161-72. PubMed ID: 15838659
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overexpression of the ATP-binding cassette half-transporter, ABCG2 (Mxr/BCrp/ABCP1), in flavopiridol-resistant human breast cancer cells.
    Robey RW; Medina-Pérez WY; Nishiyama K; Lahusen T; Miyake K; Litman T; Senderowicz AM; Ross DD; Bates SE
    Clin Cancer Res; 2001 Jan; 7(1):145-52. PubMed ID: 11205902
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of single nucleotide polymorphisms in the ABCG2 gene in a Dutch population.
    Bosch TM; Kjellberg LM; Bouwers A; Koeleman BP; Schellens JH; Beijnen JH; Smits PH; Meijerman I
    Am J Pharmacogenomics; 2005; 5(2):123-31. PubMed ID: 15813675
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ABC-transporter gene-polymorphisms are potential pharmacogenetic markers for mitoxantrone response in multiple sclerosis.
    Cotte S; von Ahsen N; Kruse N; Huber B; Winkelmann A; Zettl UK; Starck M; König N; Tellez N; Dörr J; Paul F; Zipp F; Lühder F; Koepsell H; Pannek H; Montalban X; Gold R; Chan A
    Brain; 2009 Sep; 132(Pt 9):2517-30. PubMed ID: 19605531
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The C421A (Q141K) polymorphism enhances the 3'-untranslated region (3'-UTR)-dependent regulation of ATP-binding cassette transporter ABCG2.
    Ripperger A; Benndorf RA
    Biochem Pharmacol; 2016 Mar; 104():139-47. PubMed ID: 26903388
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A functional assay for detection of the mitoxantrone resistance protein, MXR (ABCG2).
    Robey RW; Honjo Y; van de Laar A; Miyake K; Regis JT; Litman T; Bates SE
    Biochim Biophys Acta; 2001 Jun; 1512(2):171-82. PubMed ID: 11406094
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic variation and haplotype structure of the ABC transporter gene ABCG2 in a Japanese population.
    Maekawa K; Itoda M; Sai K; Saito Y; Kaniwa N; Shirao K; Hamaguchi T; Kunitoh H; Yamamoto N; Tamura T; Minami H; Kubota K; Ohtsu A; Yoshida T; Saijo N; Kamatani N; Ozawa S; Sawada J
    Drug Metab Pharmacokinet; 2006 Apr; 21(2):109-21. PubMed ID: 16702730
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic variation in the ATP-binding cassette transporter gene ABCG2 (BCRP) in a Swedish population.
    Bäckström G; Taipalensuu J; Melhus H; Brändström H; Svensson AC; Artursson P; Kindmark A
    Eur J Pharm Sci; 2003 Apr; 18(5):359-64. PubMed ID: 12694888
    [TBL] [Abstract][Full Text] [Related]  

  • 14. C421A polymorphism in the human breast cancer resistance protein gene is associated with low expression of Q141K protein and low-level drug resistance.
    Imai Y; Nakane M; Kage K; Tsukahara S; Ishikawa E; Tsuruo T; Miki Y; Sugimoto Y
    Mol Cancer Ther; 2002 Jun; 1(8):611-6. PubMed ID: 12479221
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of breast cancer resistance protein/ABCG2 phenotypes and novel promoter and intron 1 single nucleotide polymorphisms.
    Poonkuzhali B; Lamba J; Strom S; Sparreboom A; Thummel K; Watkins P; Schuetz E
    Drug Metab Dispos; 2008 Apr; 36(4):780-95. PubMed ID: 18180275
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional validation of the genetic polymorphisms of human ATP-binding cassette (ABC) transporter ABCG2: identification of alleles that are defective in porphyrin transport.
    Tamura A; Watanabe M; Saito H; Nakagawa H; Kamachi T; Okura I; Ishikawa T
    Mol Pharmacol; 2006 Jul; 70(1):287-96. PubMed ID: 16608919
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Major SNP (Q141K) variant of human ABC transporter ABCG2 undergoes lysosomal and proteasomal degradations.
    Furukawa T; Wakabayashi K; Tamura A; Nakagawa H; Morishima Y; Osawa Y; Ishikawa T
    Pharm Res; 2009 Feb; 26(2):469-79. PubMed ID: 18958403
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Breast cancer resistance protein (BCRP)-mediated glyburide transport: effect of the C421A/Q141K BCRP single-nucleotide polymorphism.
    Pollex EK; Anger G; Hutson J; Koren G; Piquette-Miller M
    Drug Metab Dispos; 2010 May; 38(5):740-4. PubMed ID: 20159988
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional analysis of SNPs variants of BCRP/ABCG2.
    Kondo C; Suzuki H; Itoda M; Ozawa S; Sawada J; Kobayashi D; Ieiri I; Mine K; Ohtsubo K; Sugiyama Y
    Pharm Res; 2004 Oct; 21(10):1895-903. PubMed ID: 15553238
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selection and characterization of a high-activity ribozyme directed against the antineoplastic drug resistance-associated ABC transporter BCRP/MXR/ABCG2.
    Kowalski P; Wichert A; Holm PS; Dietel M; Lage H
    Cancer Gene Ther; 2001 Mar; 8(3):185-92. PubMed ID: 11332989
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.